MedPath

The significance of oral L-carnitine administration in liver cirrhotic patients -a comparative study of treatment efficacy and safety between L-carnitine and lactulose in patients with minimal hepatic encephalopathy

Not Applicable
Conditions
liver cirrhosis
Registration Number
JPRN-UMIN000021808
Lead Sponsor
Kobe University Hospital Division of Gastroenterology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Those who have pregnancy, those who can not continue the treatment because of several diseases such as cancer therapy, or those who have difficulty for the enrollment of this study are excluded in this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A comparative study about the ameliorated rate of MHE
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath